TY  - GEN
AU  - Gelinck,L B S
AU  - van der Bijl,A E
AU  - Beyer,W E P
AU  - Visser,L G
AU  - Huizinga,T W J
AU  - van Hogezand,R A
AU  - Rimmelzwaan,G F
AU  - Kroon,F P
TI  - The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination
SN  - 1468-2060
PY  - 2008///1114
KW  - Adalimumab
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Viral
KW  - blood
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Autoimmune Diseases
KW  - Case-Control Studies
KW  - Crohn Disease
KW  - Etanercept
KW  - Female
KW  - Hemagglutination Inhibition Tests
KW  - Humans
KW  - Immunoglobulin G
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Influenza A Virus, H3N2 Subtype
KW  - immunology
KW  - Influenza B virus
KW  - Influenza Vaccines
KW  - administration & dosage
KW  - Influenza, Human
KW  - Male
KW  - Middle Aged
KW  - Receptors, Tumor Necrosis Factor
KW  - Time Factors
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1136/ard.2007.077552
ER  -